Agenda: Life Sciences Patent Network Europe 2019

Thursday, November 21, 2019
8:00 AM	Registration, Welcome Coffee and Networking
8:30 AM	Chairman's Opening Address Anita Varma, Partner, White & Case
8:40 AM	Artificial Intelligence & Intellectual Property in the Life Sciences Ryan Abbott, Professor of Law and Health Sciences, University of Surrey
9:00 AM	Artificial Intelligence Panel Discussion How is AI Disrupting the Patent Strategies of Life Sciences Companies? What are the Likely Implications of AI on Patenting and Licensing Strategies? How Should we now navigate the IP challenges How to Get AI-Related Patents Past the EPO How do you Develop a Trade Secrets Strategy? Assessing the European Trade Secrets Directive Moderator: Tracey Roberts, Senior Associate, Pinsent Masons Panellists: Ryan Abbott, Professor of Law and Health Sciences, University of Surrey Timo Minssen, Professor of Law , Centre for Advanced Studies in Biomedical Innovation Law, University of Copenhagen Rose Hughes, European Patent Attorney, AstraZeneca Jakob Wested, Post Doc, Faculty of Law, University of Copenhagen
9:30 AM	Inventive Step in the EPO and UK Courts: Theory and Practice Camilla Balleny, Partner, Carpmaels & Ransford Anna Leathley, Senior Associate, Carpmaels & Ransford
9:50 AM	Russian Pharma Patent Battles: Strategies and Power Moves Overview of the most Recent High-Profile Pharma Patent Court Disputes Explaining Generics Producers’ Strategies to Launch their Drugs Before Expiry Dates of Innovators' Patents and Innovators' Counter-Strategies Recommendations for Innovators Regarding how to Stop Unlawful Generics' Expansion Natalia Gulyaeva, Partner, Hogan Lovells
10:10 AM	Morning Coffee & Networking in the Exhibition Hall
10:40 AM	Developments In Life Sciences and Pharma Case Law at The EPO: A Greatest Hits Collection Edward Ronan, Patent Attorney, Boult Wade Tennant
11:10 AM	UK Focus: Enforcement: equivalents and Arrow declarations Brexit: What Practical Steps can we make to Minimise Patent Risk for Life Sciences Companies Sally Shorthose, Partner, Bird & Bird Chris de Mauny, Associate, Bird & Bird
11:35 AM	Precise Protection for Precision Medicine: Patent Protection and Orphan Drug Exclusivity in the Age of Precision Medicine Jakob Wested, Post Doc, University of Copenhagen - Faculty of Law
11:55 AM	Innovative IP Strategies for Life Sciences: Best Practice in Managing Pharma and Biotech IP in the Age of Big Data and Precision Medicine Moderator: Nicole Jadeja, Partner, Pinsent Masons Panellists: Moritz Breitenbach, Patent Attorney, B. Braun Gruppe Kristina Cornish, Partner, Kilburn & Strode Jakob Wested, Post Doc, Faculty of Law, University of Copenhagen
12:25 PM	France: the New IP Eldorado? Changes in Pls in pharma caases Biosimilars and prior use Warning letters Clear the way approaches Mathilde Rauline, European Patent Attorney, August Debouzy
12:45 PM	Lunch and Networking in the Exhibition Hall
1:55 PM	Roundtable Discussion Groups Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 40-45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunity to share knowledge and opinion.
2:00 PM	Patent and Knowhow Licensing in the Life Sciences Sector – Common Pitfalls and Shared Experiences Charlotte Tillett, Partner, Stevens & Bolton	IP considerations in Precision Medicine Isobel Finnie, Partner, Haseltine Lake Kempner	Navigating the CRISPR patent and licensing landscape Claire Irvine, Partner, HGF	Prior Art: Examining the Implications of Trade Secrets Protection Daniela Ampollini, Partner, Trevisan & Cuonzo	Strategies in Second Medical Use Cases Richard Cooke, Partner, Elkington & Fife	Strategies to Maintain Drug Monopolies and the Counter-Strategies of the Generics Otto Swens, Co-Founder, Vondst Ricardo Dijkstra, Partner, Vondst	Supplementary Protection Certificates Cumaran Arunsalam, Patent Attorney, Syngenta
2:44 PM	Please choose a discussion group for the second rotation
2:45 PM	Patent and Knowhow Licensing in the Life Sciences Sector – Common Pitfalls and Shared Experiences Charlotte Tillett, Partner, Stevens & Bolton	Supplementary Protection Certificates Cumaran Arunsalam, Patent Attorney, Syngenta	IP considerations in Precision Medicine Isobel Finnie, Partner, Haseltine Lake Kempner	Navigating the CRISPR patent and licensing landscape Claire Irvine, Partner, HGF	Prior Art: Examining the Implications of Trade Secrets Protection Daniela Ampollini, Partner, Trevisan & Cuonzo	Strategies in Second Medical Use Cases Richard Cooke, Partner, Elkington & Fife	Strategies to Maintain Drug Monopolies and the Counter-Strategies of the Generics Otto Swens, Co-Founder, Vondst Ricardo Dijkstra, Partner, Vondst
3:30 PM	Afternoon Tea and Networking in the Exhibition Hall
4:00 PM	Supplementary Protection Certificates: An In House Perspective Cumaran Arunsalam, Patent Attorney, Syngenta
4:10 PM	SPCS: Navigating Article 3(A): What Does ''Protected By Basic Patent'' Mean? Michael Pears, Partner, Potter Clarkson Joel Beevers, Patent Assistant, Potter Clarkson
4:30 PM	Evaluating the Impact of the latest Secondary Medical Use Cases Moderator: . Anita Varma, Partner, White & Case Panellists: Julia Florence, President, CIPA Trevor Crosse, Partner, Marks & Clerk Law Richard Cooke, Partner, Elkington & Fife
5:00 PM	IP Portfolio Management: In-house Counsel Day-to-Day Challenges in Prosecuting and Enforcing Patents Moderator: Richard Taylor, Partner, DLA Piper Panellists: Steven Ward, Patent Lawyer, Syngenta Andy Porter, Patent Attorney, Elasmogen Laura Reynolds, Associate General Counsel, European IP and Regulatory Litigation, Teva Ian Bryan, Senior IP Counsel, GE Healthcare
5:30 PM	Chairman's Closing Remarks & Networking Drinks Reception